Bluebird Bio vs CRISPR Therapeutics
Bluebird Bio vs CRISPR Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Bluebird Bio is on 51/100 and CRISPR Therapeutics on 64/100.
Where each one leads
Bluebird Bio
- funding raised: $1.0B against $547M
CRISPR Therapeutics
- our overall score: 64/100 against 51/100
- domain rating: 67/100 against 56/100
At a glance
| Measure | Bluebird Bio | CRISPR Therapeutics |
|---|---|---|
| What it is | Gene therapy company developing transformative treatments for severe genetic diseases. | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 1992 | 2013 |
| Headquarters | Somerville, United States | Zug, Switzerland |
| Status | Active | Active |
Size, funding and growth
| Measure | Bluebird Bio | CRISPR Therapeutics |
|---|---|---|
| Employees | 137 | Not published |
| Open roles | 16 | Not published |
| Total funding | $1.0B | $547M |
| Latest round | Series D | Series B |
| LinkedIn followers | 141,691 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Bluebird Bio | CRISPR Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 64/100 |
| Traction | 60/100 | 40/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 25/100 | 13/100 |
| Quality | 58/100 | 88/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | D (44/100) |
| Domain ratingLink authority, 0-100 | 56/100 | 67/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Bluebird Bio | CRISPR Therapeutics |
|---|---|---|
| Hosting | AWS | Self Managed |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4 |
Bluebird Bio vs CRISPR Therapeutics: common questions
Which is better, Bluebird Bio or CRISPR Therapeutics?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Bluebird Bio and CRISPR Therapeutics compare on the numbers?
Bluebird Bio leads on funding raised ($1.0B against $547M). CRISPR Therapeutics leads on our overall score (64/100 against 51/100), domain rating (67/100 against 56/100).
Read the full Bluebird Bio review and pricing or the CRISPR Therapeutics review and pricing. You can also browse other Bluebird Bio alternatives we track.